乳糖酶治疗婴幼儿腹泻病继发乳糖不耐受的疗效分析

Effect of Lactase on Infants With Infantile Diarrhea Secondary Lactose Intolerance

目的探讨乳糖酶治疗婴幼儿腹泻病继发乳糖不耐受的疗效。方法将2017年2月—2018年2月本院收治的40例婴幼儿腹泻病继发乳糖不耐受患儿纳入研究,查随机表按照患儿的入院先后顺序随机分为对照组和实验组,每组分别20例,给予对照组患儿进行常规治疗,实验组患儿在常规治疗的基础上加用乳糖酶进行治疗,分别研究两组患儿的治疗效果、止泻时间及住院时间。结果相对于对照组,实验组患儿的治疗效果更好;止泻时间及住院时间更短;P <0.05。结论在常规治疗的基础上加用乳糖酶治疗婴幼儿腹泻病继发乳糖不耐受患儿,可显著提高患儿的治疗效果,缩短住院时间和止泻时间。

Objective To investigate the efficacy of lactase in the treatment of infantile diarrhea secondary lactose intolerance.Methods From February 2017 to February 2018,40 children with secondary lactose intolerance of infantile diarrhea were enrolled in the study.According to the order of admission,the patients were randomly divided into control group and experimental group,20 cases in each group.The children in the control group were given routine treatment,and the children in the experimental group were treated with lactase on the basis of routine treatment.The therapeutic effect,the time of stopping diarrhea and the time of hospitalization were studied respectively.Results Compared with the control group,the treatment effect of the experimental group was better,the time of stopping diarrhea and the time of hospitalization were shorter than that of the control group,P<0.05.Conclusion On the basis of routine treatment,the treatment of infantile diarrhea secondary lactose intolerance can significantly improve the therapeutic effect,shorten the hospitalization time and stop diarrhea time.